Cochrane Abstracts
PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"PARP (Poly ADP‐Ribose Polymerase) Inhibitors for Locally Advanced or Metastatic Breast Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436565/all/PARP__Poly_ADP‐Ribose_Polymerase__inhibitors_for_locally_advanced_or_metastatic_breast_cancer. Accessed 13 September 2024.
PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436565/all/PARP__Poly_ADP‐Ribose_Polymerase__inhibitors_for_locally_advanced_or_metastatic_breast_cancer. Accessed September 13, 2024.
PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436565/all/PARP__Poly_ADP‐Ribose_Polymerase__inhibitors_for_locally_advanced_or_metastatic_breast_cancer
PARP (Poly ADP‐Ribose Polymerase) Inhibitors for Locally Advanced or Metastatic Breast Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 September 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436565/all/PARP__Poly_ADP‐Ribose_Polymerase__inhibitors_for_locally_advanced_or_metastatic_breast_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer
ID - 436565
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436565/all/PARP__Poly_ADP‐Ribose_Polymerase__inhibitors_for_locally_advanced_or_metastatic_breast_cancer
DB - Evidence Central
DP - Unbound Medicine
ER -
